Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).
about
The history of dopamine and levodopa in the treatment of Parkinson's diseaseCardiovascular effects of levodopa in aged versus younger patients with Parkinson's diseaseParkinson's disease and levodopa. A five-year follow-up and reviewIdentification of Adverse Drug Events from Free Text Electronic Patient Records and Information in a Large Mental Health Case RegisterLevodopa's awakening effect on patients with Parkinsonism.Does levodopa alter depression and psychopathology in Parkinsonism patients?Management of parkinson's disease--combined therapy with levodopa and thalamotomy.Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.Assessment of extrapyramidal disorders.L-DOPA in Parkinson's Disease.One to two year treatment of Parkinson's disease with levodopaIs stair negotiation measured appropriately in functional assessment scales?Dopamine and diseaseAmantadine-HCl (Symmetrel) in the management of Parkinson's disease: a double-blind cross-over studyLevodopa combined with peripheral decarboxylase inhibition in Parkinson's diseaseIdiopathic orthostatic hypotension treated with levodopa and MAO inhibitor: a preliminary report.Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease.Psychiatric aspects in Parkinsonism treated with L-dopa.An analysis of six patients with Parkinson's disease who have been unresponsive to L-dopa therapy.How do you treat motor complications in Parkinson's disease: Medicine, surgery, or both?The medical treatment of Parkinson disease from James Parkinson to George Cotzias.The effects of levodopa therapy in patients with Parkinson's disease. I. Clinical response.L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area.Levodopa and relief of Parkinsonian symptoms.Theoretical implications of the use of L-dopa in parkinsonism. A review.L-Dopa and Parkinsonism.A double-blind comparison of levodopa, Madopa, and Sinemet in Parkinson disease.Effects of levodopa therapy in patients with Parkinson's disease: statistical evidence for reduced tolerance to levodopa in the elderly.Depression in the elderly. II. Possible drug etiologies; differential diagnostic criteria.Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients.Psychiatric aspects of L-dopa therapy of Parkinson's disease.L-dopa and general anaesthesia.Combined L-dopa and amantadine in Parkinsonism.The balance of biogenic amines as condition for normal behaviourLevodopa therapy of patients with Parkinsonism and heart disease.
P2860
Q22252881-1B315827-52AC-4277-94E4-0EF1FFF0F891Q28342014-4F8D2F55-71D7-4DB5-B29E-4CBF6125A8E6Q28363594-B0FC6F74-13A4-4E0A-9350-A4AA05DCD38DQ28547303-369E29BB-5B88-4EB4-BDC7-49E4CF9B0339Q33756468-A4B86EA0-5D5E-4D86-B2AF-74E3EB683247Q33756784-2DF70466-886E-4861-B811-4493CD648F65Q33824385-4AD7AB41-CD71-4A82-9435-45CCB7C7A91BQ34062205-EEE31E22-3ABA-4377-A52F-089085E4F820Q34448515-25172FAB-F6A0-49E8-9FD9-7B1F64C6E2F3Q34769217-FD36FACE-1C42-4AE3-9F23-0E55ADEF46F0Q34769814-41971612-9FE9-4EF0-89AE-7D9D435E8B4FQ35123304-3CCF284C-0346-4C58-9758-F3F6E0D71615Q35909204-BE91B198-0863-4F92-AAC1-A6B43755A31BQ35910081-719A57E0-6B35-4E77-8A26-B901490E1397Q35926216-7AF0D3DF-FD88-4F97-A81B-82261B4DA78BQ35926508-07093B43-DC64-4A65-86D4-C293D505F082Q35927105-63D8CBAD-6A30-44C3-AB19-441A1F1E2EC3Q37079436-3F4D5E2F-03BA-47BA-9DDB-FDB149C74912Q37091013-A9A454E3-91CB-4352-B297-059BDB96F682Q37363909-759671E2-6463-4072-B0E1-7C3D3566C3DBQ38285816-1C616525-49C6-489A-8D7E-EE1DAB715191Q38516373-064180A1-370F-4B38-A27B-771D6CAC42F0Q38516636-F1885A58-6218-4166-9788-25AEAAD5F70CQ39592759-23E54F2B-3799-495D-84AA-A0344DE13A48Q39893459-BA148023-2BEF-47EB-B6B1-6C7CB2D5EEAEQ39988241-2FAB81F7-C7C0-4878-960E-F35AFE169760Q40907035-1F4A2D7E-54D6-49D8-89B7-BB78B4BBB9FFQ42232709-B0B70DB0-C083-4F1E-B3C8-B880E9F225E9Q45013188-70AB9C43-4876-4A0D-AEC5-43DF712BAAFEQ48853497-8EE94D90-8273-4290-BFF2-079ECDF91E6FQ52121364-98BD4131-4CB6-4CCC-9526-60AD97926372Q52737709-CA300D30-3F05-4E7A-815E-F0914FB677BAQ54171441-A36AEDE4-ADC5-4FB6-A3A3-27E6B71CFC7BQ54212088-DBC38470-1850-42C6-8BDE-B5D9FC4C452DQ55385997-D3B2274B-77E8-438C-B669-AD9E148C854A
P2860
Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).
description
1970 nî lūn-bûn
@nan
1970年の論文
@ja
1970年学术文章
@wuu
1970年学术文章
@zh
1970年学术文章
@zh-cn
1970年学术文章
@zh-hans
1970年学术文章
@zh-my
1970年学术文章
@zh-sg
1970年學術文章
@yue
1970年學術文章
@zh-hant
name
Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).
@en
Treatment of Parkinson's syndrome with L dihydroxyphenylalanine
@nl
type
label
Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).
@en
Treatment of Parkinson's syndrome with L dihydroxyphenylalanine
@nl
prefLabel
Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).
@en
Treatment of Parkinson's syndrome with L dihydroxyphenylalanine
@nl
P2093
P1476
Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).
@en
P2093
P356
10.7326/0003-4819-72-1-29
P407
P577
1970-01-01T00:00:00Z